The global burden of neurological conditions is staggering
.webp)
1 in 3
around the world are affected by brain disease.
1 in 8
suffering with a life-threatening condition.
11 million
lives lost each year
$3.5 trillion
annual cost of brain health disorders
We need better tools to fight it
Over the last decade, medicine has made extraordinary advances in genomics, molecular biology, precision medicine, and artificial intelligence. We understand disease better than ever. We can design increasingly sophisticated therapies. But our ability to physically access, characterize, and treat the brain has barely changed.
There is a gap between what medicine can imagine and what medicine can meaningfully do.
To close the gap, we are building a physical microrobot designed to navigate the intricate pathways of brain tissue to deliver tools and therapeutics spatially to hard-to-reach areas of the brain. Dot, as we call our proprietary multi-purpose device, will perform advanced biopsies and gather critical data from within. It will enable a new era of neuro-exploration and bespoke therapeutic action. Physicians will be able to observe, measure, and ultimately treat brain disease by delivering therapies locally, with unprecedented precision.
and solve physical bottlenecks in the brain
Safe, precise access through the brain is the physical bottleneck that has held neuroscience back for decades. Physicians are limited by stiff surgical tools that only move in a straight line, inhibiting pathology exploration and understanding. Therapeutically, treatment is almost exclusively highly toxic and delivered systemically through the blood stream, meaning that it has to traverse the body, reach the brain and cross the blood-brain-barrier in a sufficiently effective dose. It rarely works.
invasive, rigid, linear
precise, spatial, curved
introducing dot
introducing dot
Propeller
Designed to be flexible and move through brain tissue with minimal damage
Steering unit
For non-linear 3D movement
Micro engine
Dot's beating heart. The world’s smallest micro engine that powers the device
Tracking unit
For precise location monitoring
INTERCHANGeABLE Cargo
Interchangeable extensions that specify the task at hand.
Dot.Biopsy
Our first foundational application is a smart biopsy device, aiming to provide multiple spatially anatomo-localised biopsies, which will nurture personalised treatment decisions and algorithms. Site specific, patient specific and pathology specific.
Dot.Drug
A flexible microdelivery system that will be able to carry and drop therapeutic cargo precisely where it’s needed.
Dot.Electrode
A new generation electrode designed to converse with the brain for smart electrode-based stimulation to treat symptoms such as Parkinson’s disease or treatment-resistant depression, among others.
MICROWIRE
Ultra-thin tether
infrastructure to transform neurosurgery
DIAGNOSE
Building a complete, patient-specific understanding of brain disease through 3D spatial sampling across multiple sites. Moving beyond linear biopsies, we capture the full picture needed for precise, informed decisions.
Treat
Delivering targeted therapies directly within brain tissue, moving beyond one-size-fits-all approaches. By bypassing the inefficiencies of systemic delivery, we enable truly personalized treatments and maximize therapeutic impact.
Monitor
Tracking response in real time for the duration of treatment, enabling continuous assessment and immediate adjustment of therapeutic strategies. This closed feedback loop guides surgical decisions and advances our understanding of brain disease.
dot in action
Robeauté’s platform components are built on proprietary technologies developed since 2017. Every procedure generates data and runs on the same core infrastructure. Every new application expands its value.
MOM
Integrates imaging, planning, and navigation in a single surgical console. Connected in real time to the microrobot, it turns intraoperative data into actionable insights.
CAP
Launcher for robot deployment and retrieval, enabling real-time sub-millimetric tracking and seamless communication between Dot and MOM.
DOT
Carries a specific payload tailored to each procedure and medical need.
medical-first
Roughly the size of a grain of rice, our microrobots are minimally invasive by design, built using biocompatible materials and tested rigorously to ensure patient safety.
Foundational features of the microrobot have been invented and validated with more than 50+ patents, alongside ongoing pre-clinical testing ahead of clinical trials.
Dot was built with insight and continuous feedback from 100+ neurosurgeons and clinical advisors to integrate directly into current surgical processes.